Literature DB >> 12605556

Pyrosequencing AB.

Theresa McNeely1.   

Abstract

Pyrosequencing AB develops, manufactures and sells research products that enable life sciences researchers to add utility to the massive amount of genomic information available, with the goal of improving human health. As more genomic information becomes available, research efforts are shifting toward implementing practical applications of this genetic information. Pyrosequencing has developed comprehensive genotyping solutions that provide researchers with rapid and accurate technology for assessing individual genetic variation. Genotypic information is anticipated to play an important role in the emerging field of applied genomics and as a result, significant opportunities may be derived from analyzing genetic variation in individuals and across populations. These data will be key to understanding how genetic differences may be used to determine an individual's predisposition to disease, detect and monitor disease progression, and select the most appropriate therapy and dose and to avoid adverse events. This is pharmacogenomics, an area in which Pyrosequencing technology is being applied and will no doubt continue to enable researchers to ultimately improve human health.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12605556     DOI: 10.1517/phgs.4.2.217.22638

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  1 in total

Review 1.  Pyrosequencing: sequence typing at the speed of light.

Authors:  Matthew A Diggle; Stuart C Clarke
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.